Zelin Wang

882 total citations
15 papers, 188 citations indexed

About

Zelin Wang is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Zelin Wang has authored 15 papers receiving a total of 188 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in Zelin Wang's work include CAR-T cell therapy research (8 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers) and Virus-based gene therapy research (3 papers). Zelin Wang is often cited by papers focused on CAR-T cell therapy research (8 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers) and Virus-based gene therapy research (3 papers). Zelin Wang collaborates with scholars based in China, United States and Switzerland. Zelin Wang's co-authors include Zhuojun Ling, Biping Deng, Xiaoming Feng, Jinlong Xu, Alex H. Chang, Yue Tan, Jing Pan, Jiajia Duan, Weiliang Song and Xinjian Yu and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Zelin Wang

11 papers receiving 187 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zelin Wang China 5 140 53 47 39 32 15 188
Qiuxiang Wang China 8 63 0.5× 26 0.5× 38 0.8× 14 0.4× 67 2.1× 21 270
Ruyuan Li China 7 113 0.8× 21 0.4× 29 0.6× 81 2.1× 48 1.5× 35 222
Yiyang Xu United States 4 270 1.9× 42 0.8× 69 1.5× 147 3.8× 92 2.9× 7 349
Ziling Zhu China 13 137 1.0× 32 0.6× 106 2.3× 82 2.1× 87 2.7× 58 408
Cristina Martín-Lorente Spain 6 89 0.6× 28 0.5× 87 1.9× 36 0.9× 80 2.5× 15 279
Xinhe Shan United States 4 112 0.8× 29 0.5× 38 0.8× 32 0.8× 30 0.9× 7 193
Ruixiang Xia China 10 58 0.4× 13 0.2× 48 1.0× 31 0.8× 85 2.7× 25 239
Ruud Ruiter Netherlands 6 169 1.2× 41 0.8× 63 1.3× 71 1.8× 83 2.6× 8 223
David J. Savage United States 9 59 0.4× 11 0.2× 93 2.0× 39 1.0× 60 1.9× 16 264
Jia-Hua Ding China 9 41 0.3× 8 0.2× 68 1.4× 34 0.9× 102 3.2× 34 274

Countries citing papers authored by Zelin Wang

Since Specialization
Citations

This map shows the geographic impact of Zelin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zelin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zelin Wang more than expected).

Fields of papers citing papers by Zelin Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zelin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zelin Wang. The network helps show where Zelin Wang may publish in the future.

Co-authorship network of co-authors of Zelin Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Zelin Wang. A scholar is included among the top collaborators of Zelin Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zelin Wang. Zelin Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
3.
Huang, Chaoyang, Qingping Wu, Juan Wang, et al.. (2025). Regulation of sterol metabolism by gut microbiota and its relevance to disease. Gut Microbes. 17(1). 2589493–2589493.
4.
Wang, Zelin, et al.. (2025). Exploring potential drug targets for SLE through Mendelian randomization and network pharmacology. PLoS ONE. 20(1). e0316481–e0316481.
5.
6.
7.
Tan, Yue, Liping Zhao, Biping Deng, et al.. (2023). Long-term follow-up of donor-derived CD7 CAR T-cell therapy in patients with T-cell acute lymphoblastic leukemia. Journal of Hematology & Oncology. 16(1). 34–34. 49 indexed citations
8.
Zhu, Xiufang, Zelin Wang, Najla AlMasoud, et al.. (2023). Graphene/polyacrylamide interpenetrating structure hydrogels for wastewater treatment. Advanced Composites and Hybrid Materials. 6(5). 33 indexed citations
9.
Pan, Jing, Yue Tan, Biping Deng, et al.. (2023). S116: DONOR-DERIVED CD5 CAR T CELLS FOR T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA. HemaSphere. 7(S3). e3515785–e3515785. 3 indexed citations
10.
Zhao, Liping, Qi Zhou, Chen Chen, et al.. (2023). CAR T-Cell Therapy in Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia/Lymphoma: A Retrospective Study. Blood. 142(Supplement 1). 3480–3480. 1 indexed citations
11.
Deng, Biping, Chuo Li, Weiliang Song, et al.. (2021). Short-Interval Sequential CAR-T Cell Infusion May Enhance Prior CAR-T Cell Expansion to Augment Anti-Lymphoma Response in B-NHL. Frontiers in Oncology. 11. 640166–640166. 15 indexed citations
12.
Tan, Yue, Biping Deng, Zhuojun Ling, et al.. (2021). Toxicity and effectiveness of CD19 CAR T therapy in children with high-burden central nervous system refractory B-ALL. Cancer Immunology Immunotherapy. 70(7). 1979–1993. 16 indexed citations
13.
Pan, Jing, Biping Deng, Zhuojun Ling, et al.. (2021). Donor-derived CD7 CAR T cells for T-cell acute lymphoblastic leukemia.. Journal of Clinical Oncology. 39(15_suppl). 10001–10001. 2 indexed citations
14.
Pan, Jing, Biping Deng, Zhuojun Ling, et al.. (2020). Ruxolitinib mitigates steroid‐refractory CRS during CAR T therapy. Journal of Cellular and Molecular Medicine. 25(2). 1089–1099. 63 indexed citations
15.
Pan, Jing, Xiuwen Xu, Zhuojun Ling, et al.. (2019). Association of Genetic Factors with Long-Term Outcome in Refractory r/r B-ALL Patients after CAR T-Cell Therapy. Blood. 134(Supplement_1). 750–750. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qiuxiang Wang Breakdown of academic impact, for papers by Ruyuan Li Breakdown of academic impact, for papers by Yiyang Xu Breakdown of academic impact, for papers by Ziling Zhu Breakdown of academic impact, for papers by Cristina Martín-Lorente Breakdown of academic impact, for papers by Xinhe Shan Breakdown of academic impact, for papers by Ruixiang Xia Breakdown of academic impact, for papers by Ruud Ruiter Breakdown of academic impact, for papers by David J. Savage Breakdown of academic impact, for papers by Jia-Hua Ding
Rankless by CCL
2026